MECP2 and ischemic stroke: To investigate the regulatory effects of HDAC3 and p300 on MeCP2 lactylation and their impact on ischemic stroke, we treated MCAO mice with RGFP966, a selective HDAC3 inhibitor, or CTB, an activator of the p300 enzyme, 12 h after reperfusion.